Direkt zum Inhalt

Lippl, Jonas ; Reinke, Sarah ; Koch, Karoline ; Oschlies, Ilske ; Schrod, Stefan ; Wolfseher, Lukas ; Hüttl, Paul ; Huttner, Michael ; Beà, Silvia ; Campo, Elias ; Ladetto, Marco ; Cogliatti, Sergio ; Ehinger, Mats ; Rymkiewicz, Grzegorz ; Tabanelli, Valentina ; Rauert-Wunderlich, Hilka ; Rosenwald, Andreas ; Spang, Rainer ; Hoster, Eva ; Dreyling, Martin ; Altenbuchinger, Michael ; Klapper, Wolfram ; Pott, Christiane ; Klener, Pavel ; Jerkeman, Mats ; Hess, Georg ; Cordero, Francesca ; Ek, Sara ; Ferrero, Simone ; Ginè, Eva

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology

Article

Lippl, Jonas, Reinke, Sarah , Koch, Karoline, Oschlies, Ilske, Schrod, Stefan, Wolfseher, Lukas, Hüttl, Paul , Huttner, Michael , Beà, Silvia, Campo, Elias, Ladetto, Marco, Cogliatti, Sergio, Ehinger, Mats, Rymkiewicz, Grzegorz, Tabanelli, Valentina, Rauert-Wunderlich, Hilka, Rosenwald, Andreas, Spang, Rainer , Hoster, Eva, Dreyling, Martin, Altenbuchinger, Michael, Klapper, Wolfram, Pott, Christiane, Klener, Pavel, Jerkeman, Mats, Hess, Georg, Cordero, Francesca, Ek, Sara, Ferrero, Simone and Ginè, Eva (2026) Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology. Leukemia.

DOI to cite this document: 10.5283/epub.80296


Abstract

The clinical course of Mantle Cell Lymphoma (MCL) varies between individual patients. Early detection of risk is crucial to assign MCL patients to novel treatment strategies. Most of the established biomarkers of outcome require specifically trained pathologists or molecular analysis. Here we introduce MAIPI (MCL Artificial Intelligence Prognostic Index), a deep learning algorithm trained only on ...

The clinical course of Mantle Cell Lymphoma (MCL) varies between individual patients. Early detection of risk is crucial to assign MCL patients to novel treatment strategies. Most of the established biomarkers of outcome require specifically trained pathologists or molecular analysis. Here we introduce MAIPI (MCL Artificial Intelligence Prognostic Index), a deep learning algorithm trained only on Hematoxylin and Eosin (H&E) images of diagnostic biopsies of n = 428 MCL patients from clinical trials to assess prognosis. The capability of MAIPI to predict disease outcome was validated in an independent cohort of n = 140 patients treated with immunochemotherapy with and without ibrutinib. MAIPI selects areas of interest by itself and provides prognostic information independent of the MCL International Prognostic Index (MIPI) and Ki67 and without the need of molecular testing or expert pathologists evaluation.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleLeukemia
PublisherSpringer Nature
Open Access TypeDEAL (Springer) - Non UR
Date7 July 2026
Date of publication05 Aug 2026 08:50
InstitutionsMedicine > Institut für Funktionelle Genomik > Lehrstuhl für Funktionelle Genomik (Prof. Oefner)
Medicine > Institut für Funktionelle Genomik > Lehrstuhl für Statistische Bioinformatik (Prof. Spang)
Informatics and Data Science > Department Computational Life Science > Lehrstuhl für Statistische Bioinformatik (Prof. Spang)

Informatics and Data Science > Department Computational Life Science
Projects
Funded by: Bundesministerium für Bildung und Forschung (BMBF) (01KD2209A)
Identification Number
ValueType
10.1038/s41375-026-03036-8DOI
42414604PubMed ID
Dewey Decimal Classification000 Computer science, information & general works > 004 Computer science
600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgPartially
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-802963
Item ID80296

Export bibliographical data

Owner only: item control page

nach oben